14th Annual Meeting of the IHMF^®

13th Annual Meeting of the IHMF^®

12th Annual Meeting of the IHMF^®
11th Annual Meeting of the IHMF^®
10th Annual Meeting of the IHMF^®
8th Annual Meeting of the IHMF^®
7th Annual Meeting of the IHMF^®
6th Annual Meeting of the IHMF^®
Background and Scientific Information

14th Annual Meeting of the IHMF®, 2007
Keynote Lectures Cost-effectiveness and Durability of the Shingles Vaccine Impact of Herpes Virus Infection on Senescence of the Immune System CMV Vaccines: Current Status HSV Vaccine Development: Unique Questions and Confounders The Impact of Circumcision on HIV Acquisition and HSV Recurrences Recurrent Genital HSV Infections: How Brief Can Treatment Be?
Martin Wood Memorial Lecture Update: Further Analysis of the Shingles Vaccine Data
Poster Symposium In search of optimal genital herpes management and standard of care (insights) - physicians' and patients' perceptions of genital herpes The incidence of neonatal herpes in the Netherlands A randomized clinical study comparing Compeed® cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis New approach in management of patients with recurrent genital HSV-infection The prevalence and significance of CMV DNAemia in young children in South Africa Varicella zoster (VZV)-infection of the central nervous system (CNS) – PCR levels, clinical syndromes and neurological complications Human herpes virus 6 infection associated with colitis, hepatitis and pancreatitis in a lung transplant recipient
Novartis - sponsored Symposium Redefining Therapeutic Options in HSV Redefining Therapeutic Options in VZV
Menarini - sponsored Session Zoster and Quality of Life The Importance of Early Approach and of Compliance in HZ Treatment and Outcomes
Hot Topics in CMV Infections Treatment of Congenital Cytomegalovirus Infection: Impact on Hearing and Neurodevelopment Laboratory Tests to Monitor CMV Infection in Transplant Patients Ratification of New IHMF Guidelines for CMV
Hot Topics: Other Herpes Virus Infections The Development of Drug Resistance in HSV-1 to Helicase-primase Inhibitors Overview of Microbicides for HSV-2 and HIV Prevention Varicella Zoster Virus infection in pregnancy
Plenary Debate This House Believes that All Patients with Genital HSV Must Inform a New Partner Before Genital Contact Occurs
13th Annual Meeting of the IHMF®, 2006
Opening Lecture The changing epidemiology of VZV infection in a post-vaccine era: the US experience   Poster Symposium Impact of HSV-2 episodic therapy on HIV-1 and HSV-2 genital shedding and ulcer healing among women in Ghana and the Central African Republic: Randomised double-blind placebo-controlled trial (ANRS 1212 study) Reconstitution of HSV-specific T-cell immunity in HIV-infected patients receiving HAART Measuring the pain and severity associated with the prodromal phase of Herpes Zoster in Canada: A prospective community-based study   Keynote Lectures Comparison of famciclovir and valaciclovir for genital herpes suppression: new observations and issues Asymptomatic shedding of HSV-1 and HSV-2 from the oropharynx   Novartis-Sponsored Symposium The natural history of HSV-1 and -2 infections Prevention strategies for HSV-2 High Dose Famciclovir Therapy of Oral and Genital Herpes:: Review of ICAAC highlights   Hot Topics in Herpesvirus Infections Immune responses and clinical efficacy in the Shingles Prevention Study Paediatric HSV and CMV infections Antivirals for HHV-6 encephalitis in immunocompromised hosts, i.e. transplant patients A role for antiviral medications in the prevention and treatment of HHV-8-associated diseases Clinical development of SPL7013 Gel (VivaGel™), a dendrimer based microbicide for HIV and HSV-2 prevention   Menarini International Session Brivudin: an overview   Plenary Debate This house believes that genital herpes is managed optimally by the use of episodic rather than suppressive therapy: The case for This house believes that genital herpes is managed optimally by the use of episodic rather than suppressive therapy: The case against   Martin Wood Memorial Lecture Martin Wood Memorial Lecture: The impact of the shingles prevention vaccine in an elderly population
12th Annual Meeting of the IHMF®, 2005
Meeting Reports
	Report on the 12th Annual Meeting of the IHMF®, Lisbon, Portugal, October 28–30 2005
	Report on the Martin Wood Memorial Lecture: IHMF® News Issue 1 February 2006
Opening lecture Review of 2005 and future plans Plenary Abstracts: Keynote Lectures, presented at the 12th IHMF® Annual Meeting CMV vaccine potential Topical anti-herpes therapies Plenary Abstracts: Guidelines Session 1, presented at the 12th IHMF® Annual Meeting Combating VZV disease Plenary debates presented at the 12th IHMF® Annual Meeting Universal Varicella Immunization: The case for Universal Varicella Immunization: The case against   Plenary Abstracts: Guidelines Session 2, presented at the 12th IHMF® Annual Meeting   Management of PHN – statistics and reality Plenary Abstracts@ Worldwide Epidemiology presented at the 12th IHMF® Annual Meeting The continuing spread of HSV infection Frequency of HSV shedding (as measured by PCR) Martin Wood Memorial Lecture The implications of new data from ongoing varicella vaccine trials
11th Annual Meeting of the IHMF®, 2004
Opening lecture The role of HHV-8 in Kaposi's sarcoma Plenary Guidelines Session 1: Management of CMV disease, presented at the 11th IHMF® Annual Meeting Progress in the diagnosis of CMV Advances in the prevention and treatment of CMV Plenary Guidelines Session 2: Managing HSV infection in HIV-positive individuals, presented at the 11th IHMF® Annual Meeting Interactions between HSV and HIV Management of HSV infection in the immunocompromised host with HIV Effect of antiherpes therapy on HIV replication and transmission Background lectures presented at the 11th IHMF® Annual Meeting Modulation of Antigen Presentation by Herpes Simplex Virus Type I Interaction between HSV-1 and HIV-1 in AIDS pathogenesis Modeling herpes prevention: Biological and economic considerations Interaction between the HCMV DNA polymerase subunits: Toward a new antiviral target Keynote presentations from the 11th IHMF® Annual Meeting Practical considerations in diagnosing HSV infections in the clinic Clinical importance of respiratory HSV infections in ICU patients Plenary debates presented at the 11th IHMF® Annual Meeting This house believes that virus shedding is a surrogate marker for genital herpes transmission: The case for This house believes that virus shedding is a surrogate marker for genital herpes transmission: The case against Martin Wood Memorial Lecture Pain following herpes zoster: What have we learned and what are the implications for management?
10th Annual Meeting of the IHMF®, 2003

Meeting Report

Report on the Tenth Annual Meeting of the IHMF, Paris, 28 February – 2 March 2003

Opening lecture

The microbial threat and globalization: a worldwide perspective

 
Keynote presentations from the 10th IHMF^® Annual Meeting

	HSV for tumour lysis
	Herpesviruses, endogenous retroviruses and human neuropsychiatric diseases
	Laboratory diagnosis of herpesvirus infections of the central nervous system
	Neonatal herpes
	Interrupting the transmission of genital herpes with antivirals

Background lectures presented at the 10th IHMF^® Annual Meeting

	HSV meningitis
	HSV transmission and condoms: what is known?
	Modelling the epidemic of genital HSV infection: what has and is expected to happen?
	Interrupting the transmission of genital HSV-2: educational initiatives
	Neurological complications of varicella zoster virus infection

 
Plenary debates presented at the 10th IHMF^® Annual Meeting

	This house believes all persons at high risk for STDs should be screened for HSV: the argument against
	This house believes all persons at high risk for STDs should be screened for HSV: the case for

 Opening lecture

So you think condoms help protect against HSV infection?

 
Symposium presentations from the 8th IHMF^® Annual Meeting

Immunological aspects of herpesvirus infections

Keynote presentations presented at the 8th IHMF^® Annual Meeting

	Infection risks associated with xenotransplantation
	Communicating with primary care physicians: a critical assessment and proposals for improvement
	Recent advances in understanding CMV replication and dynamics
	Comparison and availability of diagnostic assays for CMV infection
	Double-blind, randomized, controlled trials in solid organ transplant recipients

 
VZV session presentations from the 8th IHMF^® Annual Meeting

	Management of pain associated with herpes zoster
	Current therapies for varicella

Interactive case histories presented at the 8th IHMF^® Annual Meeting, 2000

Interactive case histories

 
Click here to view keynote abstracts from the 8th IHMF Annual Meeting
 

 
Keynote presentations presented at the 7th IHMF^® Annual Meeting, 1999

	Diagnosis of CMV infection in pregnancy
	Changing trends in chickenpox - pregnant women and prevention with vaccine
	The prospects of vaccination against herpesviruses

Viewpoint presentations presented at the 7th IHMF^® Annual Meeting, 1999

	Serological tests for CMV and HSV: sensitivity and specificity
	Screening for HSV
	Viewpoint on screening for maternal and congenital CMV infection

Interactive case histories presented at the 7th IHMF Annual Meeting, 1999

The International Herpes Alliance - presentation given at the 7th IHMF^® Annual Meeting, 1999

  
Keynote presentations presented at the 6th IHMF^® Annual Meeting, 1998
 

Interactive case histories presented at the 6th IHMF^® Annual Meeting, 1998 

Objectives of the IHMF^®

This presentation is useful for anyone who would like to learn more about the aims and objectives of the IHMF^® itself.

 
Molecular Biology: Everything you wanted to know but were afraid to ask!

This presentation has been split into sections to make the download time quicker. There is an Acrobat file of the commentary that accompanies the slide set, explaining each of the slides.
 

	Slide commentary
	Genetic code
	Transcription
	Gene splicing
	Translation
	Protein structure
	Cell division
	Recombinant DNA
	Post-translation
	Summary